It was reported that on (b)(6) 2023, an 80 year old patient with leukemia had percutaneous intervention with implantation of two xience skypoint stents.On (b)(6) 2023 the patient¿s white blood count was noted to be significantly increased.On an unspecified date, the patient died; however, in the physician's opinion the xience skypoint stents did not cause or contribute to the death.No additional information was provided.
|
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.The reported patient effects of death and infection are listed in the xience skypoint everolimus eluting coronary stent systems instructions for use as a known patient effects of coronary stenting procedures.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|